Skip to main content
Top
Published in: Surgery Today 5/2016

Open Access 01-05-2016 | Original Article

Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax

Authors: Kosuke Fujino, Yamato Motooka, Takamasa Koga, Hironobu Osumi, Eri Matsubara, Hidekatsu Shibata, Koei Ikeda, Kenji Shiraishi, Takeshi Mori, Koji Hayashi, Kentaro Yoshimoto, Jyoeji Wakimoto, Ichiro Kubota, Makoto Suzuki

Published in: Surgery Today | Issue 5/2016

Login to get access

Abstract

Purpose

Pleurodesis is performed in patients demonstrating air leakage after lung resection and in those with pneumothorax who must avoid surgery. However, there have so far been very few reports of pleurodesis with 50 % glucose. We herein examined the feasibility and effectiveness of this novel pleurodesis technique.

Methods

Thirty-five patients after lung resection and 11 pneumothorax patients without surgery were treated with pleurodesis using 50 % glucose. Approximately, 200 mL of 50 % glucose solution was injected into the pleural space and repeated until the air leakage stopped. Cases in which the air leakage did not stop after three injections were considered to be unsuccessful and subsequently treated with conventional pleurodesis using OK-432.

Results

Thirty-nine patients were successfully treated with 50 % glucose, although 7 patients required further treatment with OK-432. The unsuccessful group had some pulmonary comorbidities (P < 0.001), and the pleural effusion volume after pleurodesis was less than that in the successful group (P < 0.001). Although the air leakage did not stop in unsuccessful patients, the amount of air leakage markedly decreased. A temporary elevation of the blood sugar level was observed in 20 patients, but no other side effects had appeared.

Conclusions

Pleurodesis with 50 % glucose is an easy, safe, and effective treatment modality. It is therefore considered to be a useful alternative method for pleurodesis.
Literature
1.
go back to reference Okereke I, Murthy SC, Alster JM, Blackstone EH, Rice TW. Characterization and importance of air leak after lobectomy. Ann Thorac Surg. 2005;79:1167–73.CrossRefPubMed Okereke I, Murthy SC, Alster JM, Blackstone EH, Rice TW. Characterization and importance of air leak after lobectomy. Ann Thorac Surg. 2005;79:1167–73.CrossRefPubMed
2.
go back to reference Liberman M, Muzikansky A, Wright CD, Wain JC, Donahue DM, Allan JS, et al. Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis. Ann Thorac Surg. 2010;89:891–7.CrossRefPubMed Liberman M, Muzikansky A, Wright CD, Wain JC, Donahue DM, Allan JS, et al. Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis. Ann Thorac Surg. 2010;89:891–7.CrossRefPubMed
3.
go back to reference Cerfolio RJ, Tummala RP, Holman WL, Zorn GL, Kirklin JK, McGiffin DC, et al. A prospective algorithm for the management of air leaks after pulmonary resection. Ann Thorac Surg. 1998;66:1726–31.CrossRefPubMed Cerfolio RJ, Tummala RP, Holman WL, Zorn GL, Kirklin JK, McGiffin DC, et al. A prospective algorithm for the management of air leaks after pulmonary resection. Ann Thorac Surg. 1998;66:1726–31.CrossRefPubMed
4.
go back to reference How Cheng-Hung, Tsai Tung-Ming, Kuo Shuenn-Wen, Huang Peo-Ming, Hsu Hsao-Hsun, Lee Jang-Ming, et al. Chemical pleurodesis for prolonged postoperative air leak in primary spontaneous pneumothorax. J Formos Med Assoc. 2014;113:284–90.CrossRefPubMed How Cheng-Hung, Tsai Tung-Ming, Kuo Shuenn-Wen, Huang Peo-Ming, Hsu Hsao-Hsun, Lee Jang-Ming, et al. Chemical pleurodesis for prolonged postoperative air leak in primary spontaneous pneumothorax. J Formos Med Assoc. 2014;113:284–90.CrossRefPubMed
5.
go back to reference Onuki T, Goto Y, Kuramochi M, Inagaki M, Sato Y. Spontaneous hemopneumothorax: epidemiological details and clinical features. Surg Today. 2014;44:2022–7.CrossRefPubMed Onuki T, Goto Y, Kuramochi M, Inagaki M, Sato Y. Spontaneous hemopneumothorax: epidemiological details and clinical features. Surg Today. 2014;44:2022–7.CrossRefPubMed
6.
go back to reference Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, et al. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Lung Cancer. 2007;58:362–8.CrossRefPubMed Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, et al. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Lung Cancer. 2007;58:362–8.CrossRefPubMed
7.
go back to reference Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994;106:1215–22.CrossRefPubMed Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994;106:1215–22.CrossRefPubMed
8.
go back to reference MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65:ii18–31.CrossRefPubMed MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65:ii18–31.CrossRefPubMed
9.
go back to reference Agarwal R, Paul AS, Aggarwal AN, Gupta D, Jindal SK. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology. 2011;16:1064–9.CrossRefPubMed Agarwal R, Paul AS, Aggarwal AN, Gupta D, Jindal SK. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology. 2011;16:1064–9.CrossRefPubMed
10.
go back to reference Kataoka M, Morishita R, Hiramatsu J, Ueoka H, Nakata Y, Ohnoshi T, et al. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion. Intern Med. 1995;34:352–6.CrossRefPubMed Kataoka M, Morishita R, Hiramatsu J, Ueoka H, Nakata Y, Ohnoshi T, et al. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion. Intern Med. 1995;34:352–6.CrossRefPubMed
11.
go back to reference Acencio MM, Vargas FS, Marchi E, Carnevale GG, Teixeira LR, Antonangelo L, Broaddus VC. Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis. Lung. 2007;185:343–8.CrossRefPubMed Acencio MM, Vargas FS, Marchi E, Carnevale GG, Teixeira LR, Antonangelo L, Broaddus VC. Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis. Lung. 2007;185:343–8.CrossRefPubMed
12.
go back to reference Nojiri S, Genba K, Aoe K, Kato K, Yamaguchi T, Sato T, et al. Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan. Pharmacoepidemiol Drug Saf. 2011;20:643–52.CrossRefPubMed Nojiri S, Genba K, Aoe K, Kato K, Yamaguchi T, Sato T, et al. Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan. Pharmacoepidemiol Drug Saf. 2011;20:643–52.CrossRefPubMed
13.
go back to reference Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E, Fleishman SB, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909–15.CrossRefPubMedPubMedCentral Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E, Fleishman SB, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909–15.CrossRefPubMedPubMedCentral
14.
go back to reference Arellano-Orden E, Romero-Falcon A, Juan JM, Ocaña Jurado M, Rodriguez-Panadero F, Montes-Worboys A. Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis. Respiration. 2013;86:201–9.CrossRefPubMed Arellano-Orden E, Romero-Falcon A, Juan JM, Ocaña Jurado M, Rodriguez-Panadero F, Montes-Worboys A. Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis. Respiration. 2013;86:201–9.CrossRefPubMed
15.
go back to reference Tsukioka T, Inoue K, Oka H, Mizuguchi S, Morita R, Nishiyama N. Pleurodesis with a 50 % glucose solution in patients with spontaneous pneumothorax in whom an operation is contraindicated. Ann Thorac Cardiovasc Surg. 2013;19:358–63.CrossRefPubMed Tsukioka T, Inoue K, Oka H, Mizuguchi S, Morita R, Nishiyama N. Pleurodesis with a 50 % glucose solution in patients with spontaneous pneumothorax in whom an operation is contraindicated. Ann Thorac Cardiovasc Surg. 2013;19:358–63.CrossRefPubMed
16.
go back to reference Chen Y, Li C, Xu L, Lin H, Cui Y, Deslauriers J. Novel treatment for chylothorax after esophagectomy with 50 % glucose pleurodesis. Ann Vasc Surg. 2010;24(694):e9–13.PubMed Chen Y, Li C, Xu L, Lin H, Cui Y, Deslauriers J. Novel treatment for chylothorax after esophagectomy with 50 % glucose pleurodesis. Ann Vasc Surg. 2010;24(694):e9–13.PubMed
17.
go back to reference Tsukioka T, Inoue K, Oka H, Mizuguchi S, Morita R, Nishiyama N. Intraoperative mechanical and chemical pleurodesis with 50 % glucose solution for secondary spontaneous pneumothorax in patients with pulmonary emphysema. Surg Today. 2013;43:889–93.CrossRefPubMed Tsukioka T, Inoue K, Oka H, Mizuguchi S, Morita R, Nishiyama N. Intraoperative mechanical and chemical pleurodesis with 50 % glucose solution for secondary spontaneous pneumothorax in patients with pulmonary emphysema. Surg Today. 2013;43:889–93.CrossRefPubMed
Metadata
Title
Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax
Authors
Kosuke Fujino
Yamato Motooka
Takamasa Koga
Hironobu Osumi
Eri Matsubara
Hidekatsu Shibata
Koei Ikeda
Kenji Shiraishi
Takeshi Mori
Koji Hayashi
Kentaro Yoshimoto
Jyoeji Wakimoto
Ichiro Kubota
Makoto Suzuki
Publication date
01-05-2016
Publisher
Springer Japan
Published in
Surgery Today / Issue 5/2016
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1223-2

Other articles of this Issue 5/2016

Surgery Today 5/2016 Go to the issue